- Home
- TNGX vs KYN Comparison
TNGX vs KYN Comparison
Compare TNGX & KYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TNGX | KYN |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.4B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | TNGX | KYN |
|---|---|---|
| Price | $26.50 | $13.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 471.3K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.99% |
| EPS Growth | ★ 26.89 | N/A |
| EPS | N/A | ★ 0.71 |
| Revenue | ★ $62,384,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $18.63 |
| Revenue Growth | ★ 48.29 | N/A |
| 52 Week Low | $1.04 | $11.31 |
| 52 Week High | $26.81 | $14.69 |
Technical Indicators
Market Signals| Indicator | TNGX | KYN |
|---|---|---|
| Relative Strength Index (RSI) | 75.87 | 34.29 |
| Support Level | $6.54 | $12.07 |
| Resistance Level | N/A | $14.45 |
| Average True Range (ATR) | 1.46 | 0.31 |
| MACD | 0.44 | -0.10 |
| Stochastic Oscillator | 91.67 | 18.75 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About KYN Kayne Anderson Energy Infrastructure Fund Inc.
Kayne Anderson Energy Infrastructure Fund, Inc is a non-diversified, closed-end fund. Its investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to the stockholder. The Company invests in various sectors, which include midstream energy companies, renewable infrastructure companies, and utility companies. The company seeks to achieve its objectives by investing a majority of its total assets in the securities of Energy Infrastructure companies.